A股異動 | 大立科技(002214.SZ)放量升近8% 股價創一個半月新高
格隆匯10月20日丨大立科技(002214.SZ)漲幅擴大至7.79%,現報27.13元創一個半月新高,成交額放大至4.1億元,總市值124.4億元。浙商證券日前指出,大立科技核心軍品佔比提升,軍民雙輪驅動。預計“十四五”期間市場容量約達100-200億元。公司2022年後有望逐步量產,打開中長期成長空間。另外,2020年公司新開拓IDC機房,有望成為新的盈利增長點。給予“買入”評級。此前曾發三季度預告,預計淨利變動260.41%~315.02%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.